The global specific pathogen free (SPF) animals market is anticipated to exhibit a healthy CAGR during the forecast period (2018 to 2023), according to a report available on Million Insights. Specific pathogen free animals is a technical term that is used for animal species which are free from infectious agents such as bacteria and virus. Such species are kept in laboratories specifically designed for research activities. Thereby, they are always kept in clean and highly monitored environment to protect them from infections due to pathogens. The moment these species get out of their bio-secure environment, they are likely to get infected.
Growing prevalence of life-threatening diseases across the globe is anticipated to propel market growth. To find effective treatment for rare diseases, healthcare professionals are continuously involved in research activities to develop valuable drugs. Thereby, for drug testing purposes, researchers do rodents which are free from any sort of infection. It helps them in finding accurate test results and in development of novel drugs for rare diseases. In addition, supportive initiatives being taken by governments across various nations to develop research facilities is also expected to impel market growth. Moreover, rising demand for specific pathogen resistant (SPR) species to perform bioassay studies will drive the market over the forecast period. SPF animals are not expected to be innately resistant to infections but they can possibly be developed into SPR species.
To cater to rising demand for various SPF animals, companies are adopting business strategies such as merger and acquisition to gain competitive edge. For instance, in June 2018, Charles River Laboratories joined UConn’s Technology Incubation Program (TIP) to continue its R&D on SPF animals. Getting into TIP’s space will allow the company to engage more people into drug discovery and development.
Based on species, the specific pathogen free (SPF) animals market can be categorized into shrimp, chicken, pig, mouse, rabbit, and others. Mouse segment is anticipated to hold highest market share over the forecast period. This is attributed to increasing use of mouse as SPF animal in laboratories for research objectives. An SPF mouse is tested regularly for evidence of infections such as mouse parvovirus, mouse hepatitis virus, ectromelia, reovirus, and others. Such tests allow researchers to eliminate contaminated animals.
On the basis of application, the market can be classified into research institutes, research organizations, and pharmaceutical companies. Research institutes segment is expected to account for largest market share over the forecast period. Regular funding from government to these institutes to support development of novel drugs is driving segment’s growth.
Regional segmentation includes Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. North America is anticipated to hold highest market share over the forecast period. This is attributed to increasing number of research institutes and research organizations in the region. Such facilities are likely to perform research activities such as drug testing on animal species that are free from infections. Thereby, pathogen free species help researchers in knowing exact effects and side effects of drug being tested. In addition, increasing investments by government and private organizations to support research activities will drive regional market growth.
Asia Pacific, on the other hand, is also expected to witness significant market share attributed to increasing number of drug development activities in the region. In addition, increasing investments by government of China, India, and South Korea to develop research institutes and organizations are likely to drive regional growth. Moreover, rising focus of established research institutes and organizations on drug discovery will drive regional market growth. For instance, Animal House project initiated by Indian Institute of Integrative Medicine is expected to provide thousands of rodents annually to researchers of Institute.
Some of the key players in the specific pathogen free animals market are Vivo Bio Tech Ltd.; Charles River Laboratories International, Inc.; Envigo; The Jackson Laboratory; and Australian BioResources.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Specific Pathogen Free (SPF) Animals in these regions, from 2012 to 2023 (forecast), covering
• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Columbia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Specific Pathogen Free (SPF) Animals market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Charles River Laboratories International
• Vivo Bio Tech
• The Jackson Laboratory
• Australian BioResources
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Specific Pathogen Free (SPF) Animals for each application, including
• Contract Research Organizations
• Research Institutes
• Pharmaceutical Companies
Research Support Specialist, USA